Adiuvo Investments S.A. (ADV.WA)
PLN 1.06
(-3.2%)
PLN 1.06
(-3.2%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 22.92 Million PLN | -36.98% |
| 2022 | 36.37 Million PLN | 19.77% |
| 2021 | 30.36 Million PLN | 21.88% |
| 2020 | 24.91 Million PLN | 166.05% |
| 2019 | 9.36 Million PLN | 173.78% |
| 2018 | 3.42 Million PLN | 363.36% |
| 2017 | -1.29 Million PLN | 71.83% |
| 2016 | -4.61 Million PLN | -7.03% |
| 2015 | -4.3 Million PLN | -155.03% |
| 2014 | 7.82 Million PLN | -2.31% |
| 2013 | 8.01 Million PLN | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 15.43 Million PLN | -31.25% |
| 2024 Q1 | 22.45 Million PLN | -2.03% |
| 2023 Q2 | 36.65 Million PLN | -0.96% |
| 2023 FY | 22.92 Million PLN | -36.98% |
| 2023 Q4 | 22.92 Million PLN | -43.38% |
| 2023 Q3 | 40.48 Million PLN | 10.46% |
| 2023 Q1 | 37 Million PLN | 1.74% |
| 2022 FY | 36.37 Million PLN | 19.77% |
| 2022 Q1 | 32.82 Million PLN | 8.09% |
| 2022 Q4 | 36.37 Million PLN | -1.97% |
| 2022 Q3 | 37.1 Million PLN | 6.11% |
| 2022 Q2 | 34.96 Million PLN | 6.53% |
| 2021 Q4 | 30.36 Million PLN | -5.69% |
| 2021 FY | 30.36 Million PLN | 21.88% |
| 2021 Q2 | 30.86 Million PLN | 11.55% |
| 2021 Q1 | 27.66 Million PLN | 11.03% |
| 2021 Q3 | 32.2 Million PLN | 4.34% |
| 2020 Q4 | 24.91 Million PLN | 21.81% |
| 2020 Q3 | 20.45 Million PLN | 12.58% |
| 2020 Q1 | 12.11 Million PLN | 29.31% |
| 2020 FY | 24.91 Million PLN | 166.05% |
| 2020 Q2 | 18.17 Million PLN | 50.03% |
| 2019 Q2 | 5.44 Million PLN | 285.41% |
| 2019 Q3 | 10.62 Million PLN | 95.31% |
| 2019 Q4 | 9.36 Million PLN | -11.85% |
| 2019 FY | 9.36 Million PLN | 173.78% |
| 2019 Q1 | -2.93 Million PLN | -185.76% |
| 2018 Q4 | 3.42 Million PLN | -55.38% |
| 2018 FY | 3.42 Million PLN | 363.36% |
| 2018 Q3 | 7.66 Million PLN | -11.48% |
| 2018 Q2 | 8.66 Million PLN | 108.55% |
| 2018 Q1 | 4.15 Million PLN | 419.71% |
| 2017 Q1 | 847 Thousand PLN | 118.37% |
| 2017 FY | -1.29 Million PLN | 71.83% |
| 2017 Q4 | -1.29 Million PLN | -132.94% |
| 2017 Q3 | 3.94 Million PLN | 193.66% |
| 2017 Q2 | -4.21 Million PLN | -597.05% |
| 2016 FY | -4.61 Million PLN | -7.03% |
| 2016 Q4 | -4.61 Million PLN | 66.07% |
| 2016 Q2 | -2.09 Million PLN | -219.08% |
| 2016 Q1 | 1.75 Million PLN | 140.76% |
| 2016 Q3 | -13.58 Million PLN | -549.88% |
| 2015 Q1 | 8.25 Million PLN | 5.42% |
| 2015 Q2 | 1.73 Million PLN | -78.93% |
| 2015 Q4 | -4.3 Million PLN | -155.4% |
| 2015 Q3 | 7.77 Million PLN | 347.15% |
| 2015 FY | -4.3 Million PLN | -155.03% |
| 2014 Q4 | 7.82 Million PLN | 0.0% |
| 2014 FY | 7.82 Million PLN | -2.31% |
| 2013 FY | 8.01 Million PLN | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Genomtec S.A. | -2.2 Million PLN | 1138.089% |
| Medinice S.A. | -9.81 Million PLN | 333.53% |
| Medicalgorithmics S.A. | -19.81 Million PLN | 215.687% |
| Synektik Spólka Akcyjna | -43.8 Million PLN | 152.327% |